Author details
Author Vissing J |
Available item(s) by this author (166)
sorted by (Issue date descending, Issue date descending, System of projection of the document ascending) | Add the result to the basket | Make a suggestion | Refine your search
Article
Zaharieva IT, Author ; Thor MG ; Oates EC ; van Karnebeek C ; Hendson G ; Blom E ; Witting N ; Rasmussen M ; Gabbett MT ; Ravenscroft G ; Sframeli M ; Suetterlin K ; Sarkozy A ; D'Argenzio L ; Hartley L ; Matthews E ; Pitt M ; Vissing J ; Ballegaard M ; Krarup C ; Slordahl A ; Halvorsen H ; Ye XC ; Zhang LH ; Lokken N ; Werlauff U ; Abdelsayed M ; Davis MR ; Feng L ; Phadke R ; Sewry CA ; Morgan JE ; Laing NG ; Vallance H ; Ruben P ; Hanna MG ; Lewis JE ; Kamsteeg EJ ; Männikkö R ; Muntoni F | 2016Comment in: When all is lost…a severe myopathy with hypotonia from sodium channel mutations. [Brain. 2016]Article
Vissing J, Author ; Barresi R ; Witting N ; van Ghelue M ; Gammelgaard L ; Bindoff LA ; Straub V ; Lochmuller H ; Hudson J ; Wahl CM ; Arnardottir S ; Dahlbom K ; Jonsrud C ; Duno M | 2016Comment in: Dominant LGMD2A: alternative diagnosis or hidden digenism? [Brain. 2017] Reply: Dominant LGMD2A: alternative diagnosis or hidden digenism? [Brain. 2017]Article
Article
Pareyson D, Author ; Fratta P ; Pradat PF ; Soraru G ; Finsterer J ; Vissing J ; Jokela ME ; Udd B ; Ludolph AC ; Sagnelli A ; Weydt P | 2016Article
Oestergaard ST, Author ; Stojkovic T ; Dahlqvist JR ; Bouchet-Seraphin C ; Nectoux J ; Leturcq F ; Cossee M ; Sole G ; Thomsen C ; Krag TO ; Vissing J | 2016Article
Article
Preisler N ; Laforet P ; Madsen KL ; Prahm KP ; Hedermann G ; Vissing CR ; Galbo H ; Vissing J | 01/04/2015OBJECTIVE: Glycogen storage disease type IIIa (GSDIIIa) is classically regarded as a glycogenosis with fixed weakness, but we hypothesized that exercise intolerance in GSDIIIa is related to muscle energy failure and that oral fructose ingestion [...]Article
Article
Andersen G ; Orngreen MC ; Preisler N ; Jeppesen TD ; Krag TO ; Hauerslev S ; Hall GV ; Vissing J | 2015Article
Article
Orngreen MC, Author ; Vissing J ; Laforet P | 2015Comment on: Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned? [J Inherit Metab Dis. 2015]Article
Article
Semplicini C, Author ; Vissing J ; Dahlqvist JR ; Stojkovic T ; Bello L ; Witting N ; Duno M ; Leturcq F ; Bertolin C ; D'Ambrosio P ; Eymard B ; Angelini C ; Politano L ; Laforet P ; Pegoraro E | 2015